2018PubMedRequires access

[Blind corticosteroid injection as primary treatment of trigger finger].

Trine Brønden Kongensgaard, Lene Schroll, Rehne Lessmann Hansen

Open publisher page 2 citations

Abstract

Trigger finger (TF) is a common condition with a lifetime prevalence up to 2%. Local corticosteroid injection at the level of the A1 pulley is a frequently used and safe treatment for TF with cure rates around 50% in randomised controlled trials, while surgical release has cure rates near 100% but more severe complications. Blind local corticosteroid injection has the same effect as ultrasound-guided local corticosteroid injection on cure rates, and the effect remains the same, whether the steroid is placed intra-sheath or extra-sheath. The treatment of TF can be carried out as blind local corticosteroid injection in general practice before possible referral to an orthopaedic specialist.

About this research paper

What this paper is about

Trigger finger (TF) is a common condition with a lifetime prevalence up to 2%. Local corticosteroid injection at the level of the A1 pulley is a frequently used and safe treatment for TF with cure rates around 50% in randomised controlled trials, while surgical release has cure rates near 100% but more severe complications. Blind local corticosteroid injection has the same effect as ultrasound-guided local corticosteroid injection on cure rates, and the effect remains the same, whether the steroid is placed intra-sheath or extra-sheath. The treatment of TF can be carried out as blind local corticosteroid injection in general practice before possible referral to an orthopaedic specialist.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Trigger finger (TF) is a common condition with a lifetime prevalence up to 2%. Local corticosteroid injection at the level of the A1 pulley is a frequently used and safe treatment for TF with cure rates around 50% in randomised controlled trials, while surgical release has cure rates near 100% but more severe complications. Blind local corticosteroid injection has the same effect as ultrasound-guided local corticosteroid injection on cure rates, and the effect remains the same, whether the steroid is placed intra-sheath or extra-sheath. The treatment of TF can be carried out as blind local corticosteroid injection in general practice before possible referral to an orthopaedic specialist.

Key concepts: Trigger finger, Corticosteroid, Medicine, Surgery, Pathology, Alternative medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Blind corticosteroid injection as primary treatment of trigger finger]. — Research Paper | ScholarLens